VanWyngarden, M.J.; Walker, Z.J.; Su, Y.; Perez de Acha, O.; Stevens, B.M.; Forsberg, P.A.; Mark, T.M.; Matsui, W.; Liu, B.; Sherbenou, D.W.
CD46–ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts. Cancers 2023, 15, 5335.
https://doi.org/10.3390/cancers15225335
AMA Style
VanWyngarden MJ, Walker ZJ, Su Y, Perez de Acha O, Stevens BM, Forsberg PA, Mark TM, Matsui W, Liu B, Sherbenou DW.
CD46–ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts. Cancers. 2023; 15(22):5335.
https://doi.org/10.3390/cancers15225335
Chicago/Turabian Style
VanWyngarden, Michael J., Zachary J. Walker, Yang Su, Olivia Perez de Acha, Brett M. Stevens, Peter A. Forsberg, Tomer M. Mark, William Matsui, Bin Liu, and Daniel W. Sherbenou.
2023. "CD46–ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts" Cancers 15, no. 22: 5335.
https://doi.org/10.3390/cancers15225335
APA Style
VanWyngarden, M. J., Walker, Z. J., Su, Y., Perez de Acha, O., Stevens, B. M., Forsberg, P. A., Mark, T. M., Matsui, W., Liu, B., & Sherbenou, D. W.
(2023). CD46–ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts. Cancers, 15(22), 5335.
https://doi.org/10.3390/cancers15225335
